BTG Competitors and Similar CompaniesClear all
BTG's competitors and similar companies include Zogenix and NIOX.
 Zogenix Specialty pharmaceutical developing CNS and pain therapies and featuring DosePro needle free delivery technology. |  NIOX NIOX (formerly Circassia) is a specialty biopharmaceutical company focused on developing novel immunotherapies | ||
Founding Date | Founding Date 1948 | Founding Date 2006 | Founding Date 2006 |
Type | Type Subsidiary | Type Subsidiary | Type Public |
Tags | |||
Locations | Locations Emeryville, US HQ Maidenhead, GB | Locations Morrisville, US HQ Bad Homburg Vor Der Höhe, DE Uppsala, SE Morrisville, US | |
Employees | Employees 650 | Employees 743% increase | Employees 91 |
Financial | |||
Revenue (est.) | Revenue (est.) £731.3m (FY, 2019) | Revenue (est.) $81.7m (FY, 2021) | Revenue (est.) £48.7m (FY, 2025) |
Cost of goods | Cost of goods £221m (FY, 2019) | Cost of goods $4.8m (FY, 2021) | Cost of goods £11.1m (FY, 2025) |
Gross profit | Gross profit £510.3m (FY, 2019) | Gross profit N/A | Gross profit £38.2m (FY, 2025) |
Net income | Net income £88.3m (FY, 2019) | Net income ($227.4m) (FY, 2021) | Net income £7m (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Zogenix
HQ
Emeryville, US
Specialty pharmaceutical developing CNS and pain therapies and featuring DosePro needle free delivery technology.
View companyNIOX
HQ
Morrisville, US
Employees
91
NIOX (formerly Circassia) is a specialty biopharmaceutical company focused on developing novel immunotherapies
View company